| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Silence Therapeutics plc | Chief Financial Officer | Employee Share Option (Right to Buy) | 375K | 02 Jan 2025 | Direct | ||
| Silence Therapeutics plc | Chief Financial Officer | Ordinary Shares | 1.5K | 02 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SLN | Silence Therapeutics plc | 02 Jan 2025 | 1 | $0 | 4 | Chief Financial Officer | 06 Jan 2025, 16:15 |
| SLN | Silence Therapeutics plc | 02 Jan 2025 | 0 | $0 | 3 | Chief Financial Officer | 02 Jan 2025, 16:32 |